UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells

Cellular and molecular life sciences : CMLS, 2021-03, Vol.78 (5), p.2081-2094

2021

Volltextzugriff (PDF)

Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases

The Journal of clinical investigation, 2019-10, Vol.129 (10), p.4539-4549

2019

Volltextzugriff (PDF)

In vivo demonstration that α-synuclein oligomers are toxic

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (10), p.4194-4199

2011

Volltextzugriff (PDF)

Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease

Stem cell reports, 2019-02, Vol.12 (2), p.213-229

2019

Volltextzugriff (PDF)

In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus

Cell stem cell, 2007-11, Vol.1 (5), p.515-528

2007

Volltextzugriff (PDF)

Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells

Current opinion in genetics & development, 2017-10, Vol.46, p.123-131

2017

Volltextzugriff (PDF)

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

Nature biotechnology, 2008-11, Vol.26 (11), p.1276-1284

2008

Volltextzugriff (PDF)

Signaling through BMPR-IA Regulates Quiescence and Long-Term Activity of Neural Stem Cells in the Adult Hippocampus

Cell stem cell, 2010-07, Vol.7 (1), p.78-89

2010

Volltextzugriff (PDF)

Dentate Gyrus-Specific Knockdown of Adult Neurogenesis Impairs Spatial and Object Recognition Memory in Adult Rats

Learning & memory (Cold Spring Harbor, N.Y.), 2009-02, Vol.16 (2), p.147-154

2009

Volltextzugriff (PDF)

Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease

EMBO molecular medicine, 2012-05, Vol.4 (5), p.380-395

2012

Volltextzugriff (PDF)

CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons

Scientific reports, 2019-05, Vol.9 (1), p.6811-6811, Article 6811

2019

Volltextzugriff (PDF)

iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation

EMBO molecular medicine, 2023-03, Vol.15 (3), p.e15847-n/a

2023

Volltextzugriff (PDF)

Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1

Genes & development, 2010-03, Vol.24 (6), p.561-573

2010

Volltextzugriff (PDF)

Robust in vivo Gene Transfer into Adult Mammalian Neural Stem Cells by Lentiviral Vectors

Proceedings of the National Academy of Sciences - PNAS, 2004-10, Vol.101 (41), p.14835-14840

2004

Volltextzugriff (PDF)

Using iPS Cells toward the Understanding of Parkinson's Disease

Journal of clinical medicine, 2015-03, Vol.4 (4), p.548-566

2015

Volltextzugriff (PDF)

Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks

Stem cell reports, 2015-10, Vol.5 (4), p.546-557

2015

Volltextzugriff (PDF)

Long-Term Labeling of Hippocampal Neural Stem Cells by a Lentiviral Vector

Frontiers in molecular neuroscience, 2018-11, Vol.11, p.415-415

2018

Volltextzugriff (PDF)

A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells

Nature protocols, 2010-04, Vol.5 (4), p.647-660

2010

Volltextzugriff (PDF)

Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises

CNS & neurological disorders drug targets, 2013-12, Vol.12 (8), p.1114

2013

Volltextzugriff (PDF)

In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice

Nature medicine, 2001-03, Vol.7 (3), p.310-316

2001

Volltextzugriff (PDF)

Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells

Stem cells and development, 2012-10, Vol.21 (15), p.2891

2012

Volltextzugriff (PDF)

Interplay of LRRK2 with chaperone-mediated autophagy

Nature neuroscience, 2013-04, Vol.16 (4), p.394-406

2013

Volltextzugriff (PDF)

Clinical potentials of human pluripotent stem cells

Cell biology and toxicology, 2017-08, Vol.33 (4), p.351-360

2017

Volltextzugriff (PDF)

Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite

Cell chemical biology, 2024-05, Vol.31 (5), p.973-988.e4

2024

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(108)
Berichte
(2)

Sprache

Englisch
(109)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(59)
Humans
(44)
Animals
(29)
Stem Cells
(27)
Cell Biology
(23)
Cells, Cultured
(18)
Mice
(18)
Parkinson's Disease
(17)
Neurons
(16)
Induced Pluripotent Stem Cells - Metabolism
(15)
Neurosciences
(13)
Cell Differentiation
(12)
Neurosciences & Neurology
(12)
Biological And Medical Sciences
(11)
Cell & Tissue Engineering
(10)
Cèl·lules Mare
(10)
Female
(10)
Life Sciences
(10)
Biomedical And Life Sciences
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells

Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases

In vivo demonstration that α-synuclein oligomers are toxic

Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease

In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2+ neural stem cells in the adult hippocampus

Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

Signaling through BMPR-IA Regulates Quiescence and Long-Term Activity of Neural Stem Cells in the Adult Hippocampus

Dentate Gyrus-Specific Knockdown of Adult Neurogenesis Impairs Spatial and Object Recognition Memory in Adult Rats

Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease

CRISPR/Cas9-mediated generation of a tyrosine hydroxylase reporter iPSC line for live imaging and isolation of dopaminergic neurons

iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation

Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1

Robust in vivo Gene Transfer into Adult Mammalian Neural Stem Cells by Lentiviral Vectors

Using iPS Cells toward the Understanding of Parkinson's Disease

Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks

Long-Term Labeling of Hippocampal Neural Stem Cells by a Lentiviral Vector

A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells

Induced pluripotent stem cell-based studies of Parkinson's disease: challenges and promises

In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice

Cyclin A1 is essential for setting the pluripotent state and reducing tumorigenicity of induced pluripotent stem cells

Interplay of LRRK2 with chaperone-mediated autophagy

Clinical potentials of human pluripotent stem cells

Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes

Identification of differential biological activity and synergy between the PARP inhibitor rucaparib and its major metabolite

Suchergebnisse filtern